Journal of Urban Health

, 85:858 | Cite as

Illicit Drug Use and Adverse Birth Outcomes: Is It Drugs or Context?

  • Ashley H. SchempfEmail author
  • Donna M. Strobino


Prenatal drug use is commonly associated with adverse birth outcomes, yet no studies have controlled for a comprehensive set of associated social, psychosocial, behavioral, and biomedical risk factors. We examined the degree to which adverse birth outcomes associated with drug use are due to the drugs versus surrounding factors. Data are from a clinical sample of low-income women who delivered at Johns Hopkins Hospital between 1995 and 1996 (n = 808). Use of marijuana, cocaine, and opiates was determined by self-report, medical record, and urine toxicology screens at delivery. Information on various social, psychosocial, behavioral, and biomedical risk factors was gathered from a postpartum interview or the medical record. Multivariable regression models of birth outcomes (continuous birth weight and low birth weight ([LBW] <2,500 g)) were used to assess the effect of drug use independent of associated factors. In unadjusted results, all types of drug use were related to birth weight decrements and increased odds of LBW. However, only the effect of cocaine on continuous birth weight remained significant after adjusting for all associated factors (−142 g, p = 0.05). No drug was significantly related to LBW in fully adjusted models. About 70% of the unadjusted effect of cocaine use on continuous birth weight was explained by surrounding psychosocial and behavioral factors, particularly smoking and stress. Most of the unadjusted effects of opiate use were explained by smoking and lack of early prenatal care. Thus, prevention efforts that aim to improve newborn health must also address the surrounding context in which drug use frequently occurs.


Illicit drugs Psychosocial factors Pregnancy Birth weight Low birth weight 



This analysis and the original study from which it is based were funded by grants from the National Institute on Drug Abuse, National Institutes of Health; R03-DA020632 (Schempf) and R01-DA007621 (Strobino), respectively.


  1. 1.
    Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: Detailed Tables. Available at: Accessed on 23 February 2008.
  2. 2.
    Arria AM, Derauf C, Lagasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern Child Health J. 2006;10(3):293–302. doi: 10.1007/s10995-005-0052-0.PubMedCrossRefGoogle Scholar
  3. 3.
    Lester BM, ElSohly M, Wright LL, et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics. 2001;107(2):309–317. doi: 10.1542/peds.107.2.309.PubMedCrossRefGoogle Scholar
  4. 4.
    Curry MA. The interrelationships between abuse, substance use, and psychosocial stress during pregnancy. J Obstet Gynecol Neonatal Nurs. 1998;27(6):692–699. doi: 10.1111/j.1552-6909.1998.tb02640.x.PubMedCrossRefGoogle Scholar
  5. 5.
    Streissguth AP, Grant TM, Barr HM, et al. Cocaine and the use of alcohol and other drugs during pregnancy. Am J Obstet Gynecol. 1991;164(5 Pt 1):1239–1243.PubMedGoogle Scholar
  6. 6.
    Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320(12):762–768.PubMedGoogle Scholar
  7. 7.
    Chiriboga CA. Fetal alcohol and drug effects. Neurologist. 2003;9(6):267–279. doi: 10.1097/01.nrl.0000094941.96358.d1.PubMedCrossRefGoogle Scholar
  8. 8.
    Bauer CR. Perinatal effects of prenatal drug exposure. Neonatal aspects. Clin Perinatol. 1999;26(1):87–106.PubMedGoogle Scholar
  9. 9.
    Schempf AH. Illicit drug use and neonatal outcomes: a critical review. Obstet Gynecol Surv. 2007;62(11):749–757.PubMedCrossRefGoogle Scholar
  10. 10.
    Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol. 2002;100(5 Pt 1):916–924. doi: 10.1016/S0029-7844(02)02199-3.PubMedCrossRefGoogle Scholar
  11. 11.
    Bada HS, Das A, Bauer CR, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005;25(10):631–637. doi: 10.1038/ Scholar
  12. 12.
    Sprauve ME, Lindsay MK, Herbert S, Graves W. Adverse perinatal outcome in parturients who use crack cocaine. Obstet Gynecol. 1997;89(5 Pt 1):674–678. doi: 10.1016/S0029-7844(97)00078-1.PubMedCrossRefGoogle Scholar
  13. 13.
    Kuhn L, Kline J, Ng S, Levin B, Susser M. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests. Am J Epidemiol. 2000;152(2):112–119. doi: 10.1093/aje/152.2.112.PubMedCrossRefGoogle Scholar
  14. 14.
    Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth. Pediatrics. 1998;101(2):229–237. doi: 10.1542/peds.101.2.229.PubMedCrossRefGoogle Scholar
  15. 15.
    Richardson GA, Hamel SC, Goldschmidt L, Day NL. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample. Pediatrics. 1999;104(2):e18. doi: 10.1542/peds.104.2.e18.PubMedCrossRefGoogle Scholar
  16. 16.
    Singer LT, Salvator A, Arendt R, Minnes S, Farkas K, Kliegman R. Effects of cocaine/polydrug exposure and maternal psychological distress on infant birth outcomes. Neurotoxicol Teratol. 2002;24(2):127–135. doi: 10.1016/S0892-0362(01)00208-2.PubMedCrossRefGoogle Scholar
  17. 17.
    Bandstra ES, Morrow CE, Anthony JC, et al. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure. Pediatrics. 2001;108(6):1309–1319. doi: 10.1542/peds.108.6.1309.PubMedCrossRefGoogle Scholar
  18. 18.
    Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol. 1995;172(1 Pt 1):19–27. doi: 10.1016/0002-9378(95)90078-0.PubMedCrossRefGoogle Scholar
  19. 19.
    Neuspiel DR, Markowitz M, Drucker E. Intrauterine cocaine, lead, and nicotine exposure and fetal growth. Am J Public Health. 1994;84(9):1492–1495.PubMedGoogle Scholar
  20. 20.
    Visscher WA, Feder M, Burns AM, Brady TM, Bray RM. The impact of smoking and other substance use by urban women on the birthweight of their infants. Subst Use Misuse. 2003;38(8):1063–1093. doi: 10.1081/JA-120017651.PubMedCrossRefGoogle Scholar
  21. 21.
    Miller JM Jr, Boudreaux MC. A study of antenatal cocaine use—chaos in action. Am J Obstet Gynecol. 1999;180(6 Pt 1):1427–1431. doi: 10.1016/S0002-9378(99)70030-X.PubMedCrossRefGoogle Scholar
  22. 22.
    Fergusson DM, Horwood LJ, Northstone K. Maternal use of cannabis and pregnancy outcome. BJOG. 2002;109(1):21–27. doi: 10.1111/j.1471-0528.2002.01020.x.PubMedCrossRefGoogle Scholar
  23. 23.
    Day N, Sambamoorthi U, Taylor P, et al. Prenatal marijuana use and neonatal outcome. Neurotoxicol Teratol. 1991;13(3):329–334. doi: 10.1016/0892-0362(91)90079-C.PubMedCrossRefGoogle Scholar
  24. 24.
    English DR, Hulse GK, Milne E, Holman CD, Bower CI. Maternal cannabis use and birth weight: a meta-analysis. Addiction. 1997;92(11):1553–1560. doi: 10.1111/j.1360-0443.1997.tb02875.x.PubMedCrossRefGoogle Scholar
  25. 25.
    Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics. 2006;118(3):1149–1156. doi: 10.1542/peds.2005-2564.PubMedCrossRefGoogle Scholar
  26. 26.
    Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol. 1990;163(5 Pt 1):1535–1542.PubMedGoogle Scholar
  27. 27.
    Bauer CR, Shankaran S, Bada HS, et al. The maternal lifestyle study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol. 2002;186(3):487–495. doi: 10.1067/mob.2002.121073.PubMedCrossRefGoogle Scholar
  28. 28.
    Bendersky M, Alessandri S, Gilbert P, Lewis M. Characteristics of pregnant substance abusers in two cities in the northeast. Am J Drug Alcohol Abuse. 1996;22(3):349–362. doi: 10.3109/00952999609001664.PubMedCrossRefGoogle Scholar
  29. 29.
    Schempf AH, Strobino DM. Drug use and limited prenatal care: an examination of responsible barriers. AJOG (In press).Google Scholar
  30. 30.
    Arias E, MacDorman MF, Strobino DM, Guyer B. Annual summary of vital statistics—2002. Pediatrics. 2003;112(6 Pt 1):1215–1230. doi: 10.1542/peds.112.6.1215.PubMedCrossRefGoogle Scholar
  31. 31.
    Breslau N, Paneth NS, Lucia VC. The lingering academic deficits of low birth weight children. Pediatrics. 2004;114(4):1035–1040. doi: 10.1542/peds.2004-0069.PubMedCrossRefGoogle Scholar
  32. 32.
    Misra DP, Guyer B, Allston A. Integrated perinatal health framework. A multiple determinants model with a life span approach. Am J Prev Med. 2003;25(1):65–75. doi: 10.1016/S0749-3797(03)00090-4.PubMedCrossRefGoogle Scholar
  33. 33.
    Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav 1995;(Spec No):80–94. doi: 10.2307/2626958.
  34. 34.
    Galea S, Nandi A, Vlahov D. The social epidemiology of substance use. Epidemiol Rev. 2004;26:36–52. doi: 10.1093/epirev/mxh007.PubMedCrossRefGoogle Scholar
  35. 35.
    Dunst CJ, Leet HE. Measuring the adequacy of resources in households with young children. Child Care Health Dev. 1987;13(2):111–125. doi: 10.1111/j.1365-2214.1987.tb00528.x.PubMedCrossRefGoogle Scholar
  36. 36.
    Curry MA, Campbell RA, Christian M. Validity and reliability testing of the Prenatal Psychosocial Profile. Res Nurs Health. 1994;17(2):127–135. doi: 10.1002/nur.4770170208.PubMedCrossRefGoogle Scholar
  37. 37.
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. doi: 10.1177/014662167700100306.CrossRefGoogle Scholar
  38. 38.
    Tinsley BJ, Holtgrave DR. Maternal health locus of control beliefs, utilization of childhood preventive health services, and infant health. J Dev Behav Pediatr. 1989;10(5):236–241. doi: 10.1097/00004703-198910000-00003.PubMedCrossRefGoogle Scholar
  39. 39.
    Straus MA. Measuring intrafamily conflict and violence: the Conflict Tactics (CT) scales. J Marriage Fam. 1979;41:75–86. doi: 10.2307/351733.CrossRefGoogle Scholar
  40. 40.
    Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923–936.PubMedGoogle Scholar
  41. 41.
    Jacobson JO, Robinson P, Bluthenthal RN. A multilevel decomposition approach to estimate the role of program location and neighborhood disadvantage in racial disparities in alcohol treatment completion. Soc Sci Med. 2007;64(2):462–476.PubMedCrossRefGoogle Scholar
  42. 42.
    Woods JR. Maternal and transplacental effects of cocaine. Ann N Y Acad Sci. 1998;846:1–11. doi: 10.1111/j.1749-6632.1998.tb09722.x.PubMedCrossRefGoogle Scholar
  43. 43.
    Orr ST, James SA, Miller CA, et al. Psychosocial stressors and low birthweight in an urban population. Am J Prev Med. 1996;12(6):459–466.PubMedGoogle Scholar
  44. 44.
    Wadhwa PD, Culhane JF, Rauh V, et al. Stress, infection and preterm birth: a biobehavioural perspective. Paediatr Perinat Epidemiol. 2001;15(Suppl 2):17–29. doi: 10.1046/j.1365-3016.2001.00005.x.PubMedCrossRefGoogle Scholar
  45. 45.
    Lindenberg CS, Reiskin HK, Gendrop SC. The social stress model of substance abuse among childbearing-age women: a review of the literature. J Drug Educ. 1994;24(3):253–268.PubMedGoogle Scholar
  46. 46.
    Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther. 1998;285(3):931–945.PubMedGoogle Scholar
  47. 47.
    Hans SL. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol. 1999;26(1):55–74.PubMedGoogle Scholar
  48. 48.
    Fiscella K. Does prenatal care improve birth outcomes? A critical review. Obstet Gynecol. 1995;85(3):468–479. doi: 10.1016/0029-7844(94)00408-6.PubMedCrossRefGoogle Scholar
  49. 49.
    Alexander GR, Korenbrot CC. The role of prenatal care in preventing low birth weight. Future Child. 1995;5(1):103–120. doi: 10.2307/1602510.PubMedCrossRefGoogle Scholar
  50. 50.
    Altarac M, Strobino D. Abuse during pregnancy and stress because of abuse during pregnancy and birthweight. J Am Med Womens Assoc. 2002;57(4):208–214.PubMedGoogle Scholar
  51. 51.
    Rajaratnam JK, Burke JG, O’Campo P. Maternal and child health and neighborhood context: the selection and construction of area-level variables. Health Place. 2006;12(4):547–556. doi: 10.1016/j.healthplace.2005.08.008.PubMedCrossRefGoogle Scholar
  52. 52.
    D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265–2281. doi: 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B.PubMedCrossRefGoogle Scholar
  53. 53.
    Reynolds EW, Bada HS. Pharmacology of drugs of abuse. Obstet Gynecol Clin North Am. 2003;30(3):501–522. doi: 10.1016/S0889-8545(03)00078-0.PubMedCrossRefGoogle Scholar
  54. 54.
    Savitz DA, Terry JW Jr, Dole N, Thorp JM Jr, Siega-Riz AM, Herring AH. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol. 2002;187(6):1660–1666. doi: 10.1067/mob.2002.127601.PubMedCrossRefGoogle Scholar
  55. 55.
    Mackenzie SG, Lippman A. An investigation of report bias in a case–control study of pregnancy outcome. Am J Epidemiol. 1989;129(1):65–75.PubMedGoogle Scholar
  56. 56.
    Delgado-Rodriguez M, Gomez-Olmedo M, Bueno-Cavanillas A, Garcia-Martin M, Galvez-Vargas R. Recall bias in a case–control study of low birth weight. J Clin Epidemiol. 1995;48(9):1133–1140. doi: 10.1016/0895-4356(94)00241-H.PubMedCrossRefGoogle Scholar

Copyright information

© The New York Academy of Medicine 2008

Authors and Affiliations

  1. 1.Department of Population, Family and Reproductive HealthJohns Hopkins Bloomberg School of Public HealthBaltimoreUSA

Personalised recommendations